Tag: FDA approval
June 14, 2018
FDA Approves Merck’s KEYTRUDA (pembrolizumab) for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration... June 13, 2018
Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%
Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new... June 13, 2018
Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer
Agilent Technologies (NYSE:A) announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3 pharmDx assay... June 13, 2018
FDA Approves Merck’s KEYTRUDA (pembrolizumab) for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration... June 13, 2018
Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy
Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) recently approved its...
June 12, 2018
Canadian Cannabis Stocks
The Canadian cannabis space is one of the hottest growing sectors. Here's a look at Canadian cannabis stocks for investors...
June 10, 2018
5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top
MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology... June 8, 2018
FDA Approves Genentech’s Rituxan (rituximab) For Pemphigus Vulgaris
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration...
May 31, 2018
8 Anti-Aging Company Stocks
Here is a look at four stocks and a big ETF searching for novel therapies in the quest for the...
May 30, 2018
